Connie Slocum B.S.



Connie Slocum

Ph.D. candidate

Address: Boston University Department of Medicine, Section of Infectious Diseases. 650 Albany st. X-620. Boston, MA 02118


Office: 617-414-5286




About Me:

I am originally from a small town in upstate New York and moved to the Boston area in 2004.  I received my B.S. in Biology with a minor in Chemistry from Eastern Nazarene College in Quincy, MA in 2008. I worked in the pharmaceutical industry for two years after graduating college before deciding to pursue a PhD. I’ve stayed in Boston because not only is it a great city, but also is one of the best places for new and exciting research!


Ph.D. candidate in Molecular Medicine, Boston University School of Medicine, Department of Medicine; Boston, MA

B.S. Eastern Nazarene College


I work with the bacterium Porphyromonas gingivalis, one of the predominate pathogens responsible for the initiation and progression of periodontal disease. Studies from the Genco laboratory have shown that this oral pathogen accelerates aortic plaque accumulation in an ApoE-/- mouse model of atherosclerosis. The goal of my project is to elucidate how this pathogen evades host innate immune defenses in order to persist in the host and subsequently contribute to chronic inflammatory atherosclerosis.


Papadopoulos, G., Kramer, C., Slocum, C., Weinberg, E., Hua, N., Gudino, C.V., Hamilton, J.A., C.A. Genco.  A Mouse Model for Pathogen-Induced Chronic Inflammation at Local and Systemic Sites. Journal of Visualized Experiments (JoVE). 2014. In Press.

Slocum CS, Coats R, Hua N, Kramer C, Papadopolous G, Weinberg EO, Gudino CV, Hamilton JA, Darveau RP, Genco CA. Distinct lipid A moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS pathogens. 2014 July 2014; 10(7): e1004215. Full Text

Genco CA, Barth K, Gudino CV, Kramer C, Slocum C, Weinberg, E, Smith J, Ingalls R, Freedman J, Ingalls R, Freedman J, Gibson F, Beaulieu L, Wetzler L, Hamilton J, shaik-Dasthagirlsaheb Y, He X, Xiuping L (Group Members). A Dangerous Response: Targeting Chronic Inflammation. 2013. International Innovation.


July 22, 2014
Primary teaching affiliate
of BU School of Medicine